miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) for Muscle Loss: Mitochondrial Evidence Breakdown

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-muscle-loss`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-muscle-loss

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-muscle-loss/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-muscle-loss/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-muscle-loss/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 5
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 3
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 6

Quantified confidence (this ledger): 0.5 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice (source s1)

Aged mice study showing mitochondrial and functional muscle benefits.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial (source s2)

Human randomized trial on ATP in aging muscle.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy (source s3)

Phase 1/2 and later phase 3 context for PMM.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat Model (source s4)

2026 rat study on muscle performance and atrophy prevention.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

SS‐31 does not prevent or reduce muscle atrophy 7 days after a 65 kdyne contusion spinal cord injury in young male mice (source s5)

Negative finding in SCI atrophy model.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

What people say on Reddit

My Experience Treating my ME/CFS with mitochondrial peptides — Reddit, r/cfs (source s6)

User reports of muscle strength changes with SS-31.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Muscle loss / sarcopenia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 6 sources · swipe →chain caa23887c391 · verify chain · provenance
Evidence ledger 6 · tier-ranked · API
preclinical
SS-31 improves mitochondrial ATP production and exercise tolerance in aged mice.
sources: s1
humanlow confidence
A single dose of elamipretide improved in vivo mitochondrial ATP production in older adult skeletal muscle in a randomized trial.
sources: s2
humanlow confidence
Phase 3 MMPOWER-3 trial in primary mitochondrial myopathy did not meet primary endpoints on walking distance or fatigue.
sources: s3
preclinicallow confidence
In a 2026 HFpEF rat model, elamipretide improved muscle contractile function and prevented atrophy.
sources: s4
preclinicallow confidence
SS-31 did not prevent muscle atrophy 7 days post-SCI in young male mice.
sources: s5
1 more ranked claim
anecdotal0.22low confidence
Anecdotal reports on Reddit include perceived muscle strength gains in some ME/CFS users.
grok/grok-4.3
Real-world user experience separate from trials.
sources: s6
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:51
SS-31 (Elamipretide) for Muscle Loss: Mitochondrial Evidence Breakdown · 6 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Muscle Loss
Slug: ss-31-muscle-loss
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],
it output
{
  "slug": "ss-31-muscle-loss",
  "title": "SS-31 (Elamipretide) for Muscle Loss: Mitochondrial Evidence Breakdown",
  "body": "## What's breaking down\n\nMuscle loss with age, often called sarcopenia, involves multiple layers. One key layer is mitochondrial decline inside muscle cells. Mitochondria produce ATP for contraction and repair. With age, they generate more reactive oxygen species, lose efficiency in oxidative phosphorylation, and show reduced ADP sensitivity. This leads to lower energy output, oxidative damage to proteins, and impaired muscle performance and maintenance. If mitochondrial dysfunction outpaces repair mechanisms, muscle mass and strength decline over time.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. If mitochondrial oxidative stress and poor ATP production contribute to your muscle loss, SS-31 binds cardiolipin in the inner mitochondrial membrane. 2. This stabilizes the membrane, improves electron transport chain efficiency, and lowers excess ROS production. 3. Therefore for you: If that layer is part of your problem, SS-31 is discussed because it targets repair (tissue) — not because it masks pain. 4. Better mitochondrial function can support muscle fiber maintenance and fatigue resistance instead of allowing further breakdown.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer of degen
82886ea729cf6b45
Machine verification: /api/articles/ss-31-muscle-loss/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "SS-31 improves mitochondrial ATP production and exercise tolerance in aged mice."?
ask ss-31-muscle-loss claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "A single dose of elamipretide improved in vivo mitochondrial ATP production in older adult skeletal muscle in a randomized trial."?
ask ss-31-muscle-loss claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Phase 3 MMPOWER-3 trial in primary mitochondrial myopathy did not meet primary endpoints on walking distance or fatigue."?
ask ss-31-muscle-loss claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In a 2026 HFpEF rat model, elamipretide improved muscle contractile function and prevented atrophy."?
ask ss-31-muscle-loss claim c4 · paste includes §SELF
What does the ledger say about this (preclinical tier): "SS-31 did not prevent muscle atrophy 7 days post-SCI in young male mice."?
ask ss-31-muscle-loss claim c5 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Anecdotal reports on Reddit include perceived muscle strength gains in some ME/CFS users."?
ask ss-31-muscle-loss claim c6 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports of muscle strength changes with SS-31."
ask ss-31-muscle-loss source s6 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for Muscle Loss: Mitochondrial Evidence Breakdown — and what would you need me to tell you first?
ask ss-31-muscle-loss condition gaps · paste includes §SELF
ss-31-muscle-loss · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 22614 tokens · $0 · 2 models
chain head 50172c91001aedb9
write grok/grok-4.3 · 2026-06-29 23:51 · 22614 tok · 1369e0bd23f4
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · 50172c91001a
verify chain →
Live ledger · 15 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:42
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 15:56
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 14:18
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 12:58
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 12:15
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 10:42
view full ledger & cards →
REST + ledger
read GET /api/articles/ss-31-muscle-loss · GET /api/articles/ss-31-muscle-loss?format=post (the editable body)
create/replace POST /api/articles/ss-31-muscle-loss · PUT /api/articles/ss-31-muscle-loss (replace, keeps revision) · PATCH /api/articles/ss-31-muscle-loss (merge)
delete DELETE /api/articles/ss-31-muscle-loss
writes need header x-terminal-key
LLM bundle GET /api/articles/ss-31-muscle-loss/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim ss-31-muscle-loss|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →